Skip to main content

QD Clinic - Audience RA Questions from RNL23

Audience Questions & Answers from RNL23 on Rheumatoid Arthritis

RNL23 was Sponsored by Abbvie – Thanks to Abbvie for their support of Rheumatology Education!

RA: Revolutionary Advances in Therapy This POD (session) devoted to advances in rheumatoid arthritis (RA) featured three excellent lectures:

- Dr. Kevin Deane – Preclinical RA – to Treat or not to treat

- Dr. Stanley Cohen – Year of the JAK inhibitors

- Dr. Michael Brenner - “Fibroblasts: Stromal Cells that hold exciting promise for treating RA.

Disclosures
The author has received compensation as an advisor or consultant on this subject

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×